SARS-CoV-2 spike protein fusion transformation: Difference between revisions
Eric Martz (talk | contribs) No edit summary |
Eric Martz (talk | contribs) No edit summary |
||
| Line 167: | Line 167: | ||
[[Image:Romeo-graphical-abstract-700px.jpg|350px]] | [[Image:Romeo-graphical-abstract-700px.jpg|350px]] | ||
</td></tr><tr><td> | </td></tr><tr><td> | ||
Graphical Abstract from Romeo, Iacovelli & Falconi<ref name="romeo" /> reproduced in accord with the COVID-19 pandemic license of Elsevier<ref name="elsevier">This quote is from the PubMedCentral version of the Romeo paper, after you click ''License Information'': Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</ref>. Permission also given by Mattia Falconi, August 12, 2020. | Graphical Abstract from Romeo, Iacovelli & Falconi<ref name="romeo" /> reproduced in accord with the COVID-19 pandemic license of Elsevier<ref name="elsevier">This quote is from the PubMedCentral version of the Romeo paper, after you click ''License Information'': "Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active."</ref>. Permission also given by Mattia Falconi, August 12, 2020. | ||
</td></tr></table> | </td></tr></table> | ||